In 2081, Dearnaley et al. [11] developed a technique for increasing the detection of breast cancer cells in the bone marrow by immunostaining bone marrow aspirate smears for epithelial membrane antigen (EMA), which is strongly expressed in breast carcinoma cells, but it is not present in normal bone marrow cells. The gene discussed is MUC1; the disease is breast carcinoma.